Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details) - Schedule of Deferred Tax Assets and Deferred Tax Liabilities

v3.24.1
Income Taxes (Details) - Schedule of Deferred Tax Assets and Deferred Tax Liabilities - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Deferred Tax Assets:      
Tax benefit of net operating loss carry-forward $ 62,608,641 $ 27,478,875  
Accrued liabilities 336,802 96,363  
Stock based compensation 223,047 949,089  
Depreciation 183,361 91,639  
Inventory reserve 29,962 27,321  
Investment impairment 448,289  
Operating lease liabilities 1,910,688 827,607  
R&D capitalization 8,793,631 5,683,784  
R&D credit 751,488 751,488  
Other 1,446,535  
Total deferred tax assets 76,732,444 35,906,166  
Deferred Tax Liabilities:      
Amortization (3,078)  
Intangibles (6,450,630) (5,885,385)  
Deferred rent (1,379,646) (798,745)  
Total deferred tax liabilities (7,830,276) (6,687,208)  
Total net deferred tax assets 68,902,168 29,218,958  
Valuation allowance for deferred tax assets (68,902,168) (29,218,958) $ (14,528,920)
Deferred tax assets, net of valuation allowance